NOVO NORDISK A S (NVO)

About NOVO NORDISK A S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Headquarters: Bagsvaerd · Employees: 67900 · Website: https://www.novonordisk.com

Related Macro Trends

• Gene Therapy & Precision Medicine

Product categories

• Cell Culture Media & Reagents
• Bioreactors & Fermenters
• Single-Use Systems & Bags
• Upstream Processing Equipment
• Fill-Finish & Sterile Filling
• Cold Chain Logistics & Storage
• Biologics CDMO Services
• mAb & GLP-1 Production Capacity
• Drug Discovery & Development

Supply-chain relationships for NVO

• Cencora, Inc. (COR) — supplier
• GE HealthCare Technologies Inc. (GEHC) — partner
• WEST PHARMACEUTICAL SERVICES INC (WST) — supplier
• Stevanato Group S.p.A. (STVN) — supplier

Competitors of NOVO NORDISK A S

• ELI LILLY & Co (LLY)
• Bayer Aktiengesellschaft (1BAYN.MI)
• THERMO FISHER SCIENTIFIC INC. (TMO)
• JOHNSON & JOHNSON (JNJ)
• AbbVie Inc. (ABBV)
• Merck & Co., Inc. (MRK)
• AMGEN INC (AMGN)
• PFIZER INC (PFE)
• IQVIA HOLDINGS INC. (IQV)
• Medpace Holdings, Inc. (MEDP)
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
• ICON PLC (ICLR)

Frequently asked questions about NOVO NORDISK A S (NVO)

What is NOVO NORDISK A S (NVO)?

NOVO NORDISK A S (NVO) is a publicly traded company in the Pharmaceutical Preparations sector (Drug Manufacturers - General), listed on NYSE. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are NOVO NORDISK A S's key suppliers and customers?

Macroplane tracks NOVO NORDISK A S's (NVO) supply chain. Key suppliers include Cencora, Inc. (COR), WEST PHARMACEUTICAL SERVICES INC (WST), Stevanato Group S.p.A. (STVN).

Who are NOVO NORDISK A S's main competitors?

Competitors of NOVO NORDISK A S (NVO) tracked by Macroplane include ELI LILLY & Co (LLY), Bayer Aktiengesellschaft (1BAYN.MI), THERMO FISHER SCIENTIFIC INC. (TMO), JOHNSON & JOHNSON (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), AMGEN INC (AMGN), PFIZER INC (PFE), and 4 more.